Ashley McEvoy is a top Fortune 50 executive and board member with nearly three decades' experience creating transformational change in health care. She is highly regarded for her track record of driving growth and innovation across Johnson & Johnson and leading many of its most important businesses, as well as her visionary, human centric leadership and passion for improving patient lives.
As the former Executive Vice President and Worldwide Chairman of Johnson & Johnson's MedTech division, Ashley led an organization with 60,000 global employees and revenue of more than $30 billion in 2023. During her five-year tenure, Ashley orchestrated a remarkable turnaround of the MedTech business, tripling revenue growth from 1.5% to 7.8%. She executed a targeted business transformation strategy to strengthen the portfolio, leading the deployment of $22 billion in capital to push into higher growth markets such as heart failure, vision, and robotics, and increasing investment in R&D, doubling the value of the new product pipeline. As a direct result of her vision and leadership, 50% of the MedTech portfolio is now projected to be in higher- growth markets, compared with 20% in 2018.
Prior to leading MedTech, Ashley served as Johnson & Johnson's Group Chairman, Consumer Medical Devices; Group Chairman, Vision Care; Worldwide President, Ethicon Products; President, McNeil Consumer Healthcare; and held a number of management, marketing and brand management roles in OTC and other consumer health care.
Ashley currently serves on the Board of Directors of Procter & Gamble as well as the Board of Trustees for the internationally renowned Children's Hospital of Philadelphia (CHOP). She has been named to several prestigious lists including FORTUNE's "Future Fortune 500 CEOs," Forbes' inaugural "CEO NEXT" list, and in 2019 was named to FORTUNE'S Most Powerful Women list. A Philadelphia native and graduate of the University of Pennsylvania, Ashley is a mother of five children and one Siberian husky and enjoys staying active with family, friends, and colleagues.
